Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Patidegib

EU orphan designation number: EU/3/18/1998   
Active ingredient: Patidegib
Indication: Treatment of naevoid basal-cell carcinoma syndrome (Gorlin syndrome)
Sponsor: Blue-Reg Europe
1800 route des Crêtes, Les 2 Arcs Bâtiment A, 06 560 Valbonne, France

  

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
23/03/2018 Orphan designation EMA/OD/206/17 (2018)1887 of 21/03/2018